2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 113 filers reported holding 2SEVENTY BIO INC in Q2 2024. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $611,426 | -32.7% | 162,182 | -4.5% | 0.00% | -50.0% |
| Q1 2024 | $909,003 | -34.3% | 169,907 | -47.5% | 0.00% | -33.3% |
| Q4 2023 | $1,382,694 | +22.7% | 323,816 | +8.4% | 0.00% | +50.0% |
| Q3 2023 | $1,126,608 | +656.7% | 298,835 | +1931.4% | 0.00% | – |
| Q2 2023 | $148,875 | +7.2% | 14,711 | +6.5% | 0.00% | – |
| Q1 2023 | $138,841 | +45.6% | 13,815 | +27.8% | 0.00% | – |
| Q4 2022 | $95,353 | – | 10,811 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newtyn Management, LLC | 465,294 | $11,925,000 | 3.17% |
| VIRGINIA RETIREMENT SYSTEMS ET Al | 13,165 | $337,419,000 | 2.30% |
| EcoR1 Capital, LLC | 1,917,063 | $49,134,000 | 1.57% |
| Birchview Capital, LP | 27,999 | $718,000 | 0.46% |
| Sessa Capital IM, L.P. | 342,002 | $8,766,000 | 0.43% |
| Parametrica Management Ltd | 14,766 | $379,000 | 0.38% |
| Bain Capital Life Sciences Investors, LLC | 179,393 | $4,598,000 | 0.36% |
| ARMISTICE CAPITAL, LLC | 856,000 | $21,939,000 | 0.36% |
| Virtus ETF Advisers LLC | 13,134 | $337,000 | 0.13% |
| CAAS CAPITAL MANAGEMENT LP | 202,118 | $5,180,000 | 0.13% |